Results 301 to 309 of about 446,523 (309)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Philip J Mease, Bruce W Kirkham, Arthur Kavanaugh   +2 more
exaly  

Interleukin-6: designing specific therapeutics for a complex cytokine

Nature Reviews Drug Discovery, 2018
Christoph Garbers, Sylvia Heink, Stefan Rose-John   +2 more
exaly  

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

Lancet, The, 1993
Sc Donnelly
exaly  

Signaling and Function of Interleukin-2 in T Lymphocytes

Annual Review of Immunology, 2018
Sarah H Ross, Doreen A Cantrell
exaly  

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran, Linda A Dimeglio, Carla J Greenbaum   +2 more
exaly  

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock

Lancet, The, 2004
Ash A Alizadeh, Steven B Welch, Simon Nadel   +2 more
exaly  

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

New England Journal of Medicine, 2012
Claus Otto Carl Zachariae
exaly  

The Role of Interleukin-1 in Disease

New England Journal of Medicine, 1993
exaly  

HIGH EXPRESSION OF TOLL LIKE RECEPTORS 7 AND INTERLEUKIN 18 IN LUPUS NEPHRITIS.

2012
SPINELLI, FRANCESCA ROMANA, S. Truglia, ALESSANDRI, cristiano, M. Bombardieri, F. Ceccarelli, F. Martinelli, F. Miranda, V. Conti, C. Perricone, GIANNAKAKIS, Konstantinos, T. Faraggiana, VALESINI, Guido, CONTI, FABRIZIO   +12 more
openaire   +1 more source